Evestra (United States)

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling

Hari Singhal, Marianne E. Greene, Allison L. Zarnke et al. · Oncotarget · 2017 · 74 citations · Full text

Life Sciences, Endocrinology, Oncology +15

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer

Weiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar Mulampurath Achuthan Pillai et al. · Cell Death Discovery · 2021 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

Controlled-Release from High-Loaded Reservoir-Type Systems—A Case Study of Ethylene-Vinyl Acetate and Progesterone

Ioannis Koutsamanis, Amrit Paudel, Klaus Nickisch et al. · Pharmaceutics · 2020 · 32 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma

Bradley R. Hall, Andrew Cannon, Christopher M. Thompson et al. · Genes & Cancer · 2018 · 32 citations · Full text

Medicine, Cell Biology, Oncology +17

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Kristin A. Altwegg, Suryavathi Viswanadhapalli, Monica Mann et al. · Cancer Research · 2022 · 27 citations · Full text

Life Sciences, Molecular Biology, Oncology +14